Frequency of polymorphic loci of GSTM1 and GSTT1 modifier genes in the genotype of children with pyelonephritis and congenital urinary malformations
More details
Hide details
Department of Clinical Genetics, Institute of Hereditary Pathology of the National Academy of Medical Sciences of Ukraine, Lviv, Ukraine
Department of Propaedeutics of Pediatrics and Medical Genetics, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
College of Medicine, Ajman University; Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates
Department of Bioorganic and Biological Chemistry and Clinical Biochemistry, Bucovinian State Medical University, Chernivtsi, Ukraine
Department of Fundamental Disciplines with a Course of Traditional and Non-traditional Medicine, Dnipro Medical Institute of Traditional and Non-traditional Medicine, Dnipro, Ukraine
Nataliia Lukyanenko   

Department of Clinical Genetics, Institute of Hereditary Pathology of the National Academy of Medical Sciences of Ukraine, 79008, 31a M. Lysenko Str., Lviv, Ukraine.
Submission date: 2022-01-14
Final revision date: 2022-04-14
Acceptance date: 2022-04-15
Online publication date: 2022-09-20
The growing number, prevalence, numerous complications, and deaths in patients with congenital anomalies of the kidney and urinary tract (CAKUT) indicate the high relevance of the declared topic. Currently, clinical medicine is actively engaged in research on the cellular and molecular mechanisms that cause the appearance of these diseases.

The aim of the work is to study genetic markers of CAKUT and the tendency to a more severe course of pyelonephritis in young children.

Material and methods:
Using the multiplex polymerase chain reaction method, 50 children with pyelonephritis were examined for the presence of deletion alleles of the glutathione S-transferase mu 1 (GSTM1) and glutathione S-transferase theta 1 (GSTT1) genes.

Results and discussion:
As a result, 35 children were diagnosed with certain CAKUT. A statistically significant associative relationship between the development of pyelonephritis in a child and the presence of a null allele GSTM1 0/0 in its genotype and a high probability of CAKUT with quantitative and positional anomalies and impaired formation and differentiation of renal tissue in carriers of null alleles GSTT1 0/0, GSTM1 0/0 in their combination was revealed.

The fact that different forms of abnormalities are detected in members of the same family suggests that certain genetic mutations can potentially lead to CAKUT syndrome, but the final phenotype of the renal system depends either on the genetic background or on environmental factors.

None declared.
None declared.
Antonova V. [Analysis of the frequency and structure of malformations of the urinary and reproductive system in newborn children in Omsk] [in Russian]. Pediatr. 2010;3:135–137. Accessed: 14.09.2022.
Chesnaye N, Bonthuis M, Schaefer F, et al. Demographics of paediatric renal replacement therapy in Europe: A report of the ESPN/ERA-EDTA registry. Pediatr Nephrol. 2014;29(12):2403–2410.
Nicolaou N, Renkema KY, Bongers EM, et al. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat Rev Nephrol. 2015;11(12):720–731.
Gong Y, Zhang Y, Shen Q, et al. Early detection of congenital anomalies of the kidney and urinary tract: cross-sectional results of a community-based screening and referral study in China. BMJ Open. 2018;8(5):e020634.
Weber S, Landwehr C, Renkert M, et al. Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol Dial Transplant. 2011;26(1):136–143.
Silva E, Cesa TN. A path to safety in gene editing. Med Law. 2022;41(1):85–100.
Hwang DY, Kohl S, Fan X, et al. Mutations of the SLIT2-ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and uri nary tract. Hum Genet. 2015;134(8):905–916.
Yosypiv IV. Congenital anomalies of the kidney and urinary tract: A genetic disorder? Int J Nephrol. 2012;909083.
Hausman-Cohen SR, Hausman-Cohen LJ, Williams GE, Bilich CE. Genomics of detoxification: How genomics can be used for targeting potential intervention and prevention strategies including nutrition for environmentally acquired illness. J Am Coll Nutr. 2020;39(2):94–102.
Nasseri G, Zahedi T, Mousavi-Kazerooni F, Saadat M. Prevalence of null genotypes of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) in seven Iranian populations. Iran J Public Health. 2015;44(12):1655–1661.
Ercegovac M, Jovic N, Sokic D, et al. GSTA1, GSTM1, GSTP1 and GSTT1 polymorphisms in progressive myoclonus epilepsy: A Serbian case-control study. Seizure. 2015;32:30–36.
Buchard A, Sanchez JJ, Dalhoff K, et al. Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant. J Mol Diagn. 2007;9(5):612–617.
Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: When and how? Nephrol Dial Transplant. 2016;31(11):1802–1813.
Cao M, Mu X, Jiang C, Yang G, Haige Chen, Wei Xue. Single-nucleo-tide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: A systematic review and meta-analysis. Tumour Biol. 2014;35(1):759–764.
Allocati N, Masulli M, di Ilio C, Federici L. Glutathione trans-ferases: Substrates, inihibitors and pro-drugs in cancer and neu-rodegenerative diseases. Oncogen. 2018;7(1):8.
Pisani P, Srivatanakul P, Randerson-Moor J, et al. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: A study in rural Thailand. Cancer Epidemiol Biomarkers Prev. 2006;15(4):667–674.
Rostami G, Assad D, Ghadyani F, et al. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response. Mol Genet Genomic Med. 2019;7(7):e00717.
Sanna-Cherchi S, Kiryluk K, Burgess KE, et al. Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Gen. 2012;91(6):987–997.
Vivante A, Mann N, Yonath H, et al. A dominant mutation in nuclear receptor interacting protein 1 causes urinary tract malformations via dysregulation of retinoic acid signaling. J Am Soc Nephrol. 2017;28(8):2364–2376.
Styczewska M, Krawczyk MA, Nowak P, Kaczorowska A, Bień E. Delayed diagnosis of pediatric bladder and prostate rhabdomyosarcoma – causes and consequences. Pol Ann Med. 2021;28(1):72–76.
Cimbaljevic S, Suvakov S, Matic M, et al. Association of GSTO1 and GSTO2 polymorphism with risk of end-stage renal disease development and patient survival. J Med Biochem. 2016;35(3):302–311.
Lee KH, Gee HY, Shin JI. Genetics of vesicoureteral reflux and congenital anomalies of the kidney and urinary tract. Investig Clin Urol. 2017;58(Suppl 1):S4–13.
Ninoa F, Ilaria M, Noviello C, et al. Genetics of vesicoureteral reflux. Curr Genom. 2016;17(1):70–79.
Song R, Yosypiv IV. Genetics of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol. 2011;26(3):353–364.
Arand M, Muhlbauer R, Hengstler J, et al. A multiplex polymerase chain reaction for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem. 1996;236(1):184–186.
Pechenik SO, Lukyanenko NS, Hakobyan GR, et al. Features of glutathione-S-transferase activity in the body of children under the influence of various factors of environmental pollution [in Ukrainian]. Odessa Med J. 2007;3(101):76–81. Accessed: 13.09.2022.
Dhaliwal A. DNA Extraction and purification. Labome. 2013;3:191.
Andreoli V, Sprovieri F. Genetic aspects of susceptability to mercury toxicity: An overview. Int J Environ Res Public Health. 2017;14(1):93.
Kim Y, Cha S-J, Choi H-J, Kim K. Omega class glutathione s-transferase: Antioxidant enzyme in pathogenesis of neurodegenerative diseases. Oxid Med Cell Longev. 2017;5049532.
Sanna-Cherchi S, Westland R, Ghiggeri GM, Gharavi AG. Genetic basis of human congenital anomalies of the kidney and urinary tract. J Clin Invest. 2018;128(1):4–15.
Del Villar OG, Barrios Peña K. Urinary tract infection in pediatrics: Clinical approach and follow up. Rev Salud Uninor. 2018;34(1):203–211.
Hinfey P. Pediatric Pyelonephritis. 2018. Accessed: 13.09.2022.
Lee H, Choi JH, Kang D-H, Kim S, Kang K-S, Han KH. Predictive markers for screening renal damage in children with urinary tract infections and vesicoureteral reflux. 2020.
Capone V, Morello W, Taroni F, Montini G. Genetics of congenital anomalies of the kidney and urinary tract: The current state of play. Int J Mol Sci. 2017;18(4):796.
Harshman VP, Kryuchko TO, Kolenko IO, Kushnereva TV, Tkachenko OY. Role of genetic mutations in development of immunological and clinical disorders in children with chronic pyelonephritis. Wiad Lek. 2017;70(1):47–51. https://pubmed.ncbi.nlm.nih.go....
Brandström P, Lindén M. How Swedish guidelines on urinary tract infections in children compare to Canadian, American and European guidelines. Acta Paediatr. 2021;110:1759–1771.
Szychlińska M, Gontarz-Nowak K, Matuszewski W, Myszka-Podgórska K, Bandurska-Stankiewicz E. Diagnostic criteria for metabolic syndrome: A historical overview. Pol Ann Med. 2020;27(2):244–249.